LQQ:PA:PA-Lyxor UCITS NASDAQ-100 Daily Leverage (EUR)

ETF | Others |

Last Closing

USD 1124.2

Change

0.00 (0.00)%

Market Cap

USD 0.62B

Volume

7.02K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-06-15 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
JPX4:PA Amundi Index Solutions - Amund..

+0.52 (+1.20%)

USD 66.11B
SPY5:PA SPDR® S&P 500 UCITS ETF EUR

-1.00 (-0.20%)

USD 11.38B
WRD:PA HSBC ETFs Public Limited Compa..

-0.04 (-0.13%)

USD 9.27B
MEUD:PA Amundi Stoxx Europe 600 UCITS ..

-0.62 (-0.26%)

USD 7.87B
EQQQ:PA Invesco EQQQ NASDAQ-100 UCITS ..

+1.45 (+0.32%)

USD 7.28B
HHH:PA HSBC ETFs Public Limited Compa..

-0.09 (-0.17%)

USD 6.91B
WLD:PA Lyxor UCITS MSCI World D-EUR

-0.17 (-0.05%)

USD 6.48B
LCWD:PA Multi Units Luxembourg - Lyxor..

-0.02 (-0.09%)

USD 5.45B
SP5C:PA Lyxor S&P 500 UCITS ETF - C-EU..

-0.56 (-0.15%)

USD 4.39B
500U:PA Amundi Index Solutions - Amund..

-0.39 (-0.37%)

USD 4.25B

ETFs Containing LQQ:PA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 36.27% 95% A 95% A
Dividend Return N/A N/A N/A N/A N/A
Total Return 36.27% 95% A 94% A
Trailing 12 Months  
Capital Gain 57.76% 93% A 95% A
Dividend Return N/A N/A N/A N/A N/A
Total Return 57.76% 93% A 93% A
Trailing 5 Years  
Capital Gain 360.55% 100% F 99% N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return 360.55% 100% F 99% N/A
Average Annual (5 Year Horizon)  
Capital Gain 40.42% 96% N/A 94% A
Dividend Return 40.42% 96% N/A 98% N/A
Total Return N/A 59% D- 63% D
Risk Return Profile  
Volatility (Standard Deviation) 50.86% 7% C- 55% F
Risk Adjusted Return 79.47% 87% B+ 94% A
Market Capitalization 0.62B 75% C 73% C

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.